A $100 Billion Opportunity Just Getting Started

Описание: The cure for cancer - at least today - is early detection. That's because if you can detect cancer soon enough, the chance for survival increases dramatically. We've identified two pure-play companies using blood tests for cancer detection, what's known as "liquid biopsy." Those companies are Guardant Health $GH and GRAIL $GRAL. Both offer a "multi-cancer" test, meaning you can screen for multiple cancers with a single blood sample. The market opportunity is measured in the hundreds of billions of dollars. Can these companies succeed where Theranos failed?

RESEARCH PIECES USED IN THIS VIDEO:
1. The Massive Cancer Blood Test Opportunity
https://www.nanalyze.com/2025/01/the-...
2. Guide to Biotech Investing
   • The Only Guide to Biotech Investing You'll...  

CHAPTERS:
00:00 Intro
01:13 The multi-cancer screening opportunity
02:49 The low-hanging fruit in cancer screening
04:04 The problem with cancer screening today
04:30 GRAIL's Galleri test
07:35 Cancer testing market
09:58 Guardant Health liquid biopsy
12:17 Other cancer testing players
16:53 Conclusion

ABOUT US:
This video is brought to you by Nanalyze, a media and research firm founded by finance professionals with decades of experience. We share insights about #DisruptiveTechnology #stocks in a language that is future-proof and easy to understand.

Read all the Nanalyze Premium articles you'd like for free! Sign up for a 30-day trial of our monthly subscription with no strings attached: https://www.nanalyze.com/subscription...

DISCLAIMER: Our content is intended to be used and must be used for informational purposes only. It is very important to do your own analysis before making any investment based on your own personal circumstances. You should take independent financial advice from a professional in connection with, along with independently researching and verifying, any information contained within our YouTube videos or on our website, whether for the purpose of making an investment or otherwise.

#cancer
#cancertesting
#biotechstocks
#biotechinvesting